This report, Histology and Cytology IVD Market Update, 2024, provides competitive analysis of the histology/cytology market from 2023 to 2028. Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination. Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the knowledge and understanding of the shape-function relationships within tissues and organs and their relationship to disease.
The industry has forged ahead with new technologies that offer increased accuracy and automated workflow. In the coming years, digital imaging, quantitative microscopy, precision microscopy, artificial intelligence and virtual histology will take the histology/cytology industry to the next level.
As discussed in the report, the histology market is a growing market with much potential. This report only looks at traditional histology. The histology report is segmented into five areas:
Traditional non-PAP Stains
PAP
In situ Hybridization
Immunohistochemistry
HPV
The histology report also examines and profiles five key market participants:
Agilent
Danaher Corporation
Hologic
Illumina
Roche Diagnostics
Scope and Methodology
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests. The base year for data was 2023. Data are provided for 2023 and 2028 with compound annual growth rates (CAGRs) for 2023 and 2028. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, Europe, Asia-Pacific and Rest of World for 2023. The forecasted market analysis for 2023-2028 was largely based on demographic trends, new developments, innovative technology and global expansion.
Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Table Global Histology IVD Market, 2023-2028 ($ millions)
Competitive Outlook
Market Overview
Overview Of Histology/Cytology
Histology and Cancer
Advanced Analysis Solutions
Table Selected Advanced Histology Techniques
Laboratory Developed Tests
AI and Histology
Market Size and Growth
Market Segments
Table Global Histology/Cytology Sales, by Type (Pap Tests, In situ hybridization, Immunohistochemistry, Traditional non-Pap stains, HPV), 2023-2028 ($ millions)
Table Global Histology/Cytology IVD Market, 2023-2028 ($ millions)
Table Histology/Cytology Diagnostic Market Distribution, by Broad Test Category (Pap Tests, In situ hybridization, Immunohistochemistry, Traditional non-Pap stains, HPV), 2023 (%)
Traditional Tissue Stains
Table Selected Vendors of Traditional Histology Stains
PAP Tests
Table Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2022 (last updated 2022-5-6)
Immunohistochemistry and In Situ Hybridization
Table Selected in Situ Hybridization-based Tests
Table Selected IHC Test Innovations
HPV
Table HPV Screening Market: HPV DNA and Pap Test Distribution of Sales, 2023
Table Global HPV Molecular (DNA/RNA) Test Sales Distribution, by Region (North America, Europe, Asia Pacific, RoW), 2023 (%)
Table Selected HPV Test Innovations
Market by Region
Table Global Histology/Cytology Market, by Region (North America, Europe, Asia, RoW), 2023-2028 ($ millions)
Table Global Histology/Cytology Market, by Region (North America, Europe, Asia, RoW), 2023-2028 (%)
Table Global Histology/Cytology Sales Distribution, by Region (North America, Europe, Asia Pacific, RoW), 2023 (%)
North America
Table North America Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 ($ millions)
Table North America Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 (%)
Europe
Table Europe Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 ($ millions)
Table Europe Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 (%)
Asia Pacific
Table Asia Pacific Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 ($ millions)
Table Asia Pacific Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 (%)
Rest of World (RoW)
Table Rest of World (RoW) Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 ($ millions)
Table Rest of World (RoW) Histology/Cytology Market, by Segment (Pap Test, In situ hybridization, Immunohistochemistry, Traditional non-Pap test, HPV-DNA), 2023-2028 (%)
Competitive Analysis
Table Revenues of the Major Histology Companies, 2017-2023 ($ millions, estimated)